Johnson & Johnson (JNJ)
(Delayed Data from NYSE)
$155.17 USD
-0.33 (-0.21%)
Updated Nov 22, 2024 04:00 PM ET
After-Market: $155.35 +0.18 (0.12%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth F Momentum C VGM
Johnson & Johnson (JNJ) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$175.95 | $215.00 | $159.00 | 13.15% |
Find the top stocks with the greatest target price potential and Zacks Rank of 1 or 2
Price Target
Based on short-term price targets offered by 22 analysts, the average price target for Johnson & Johnson comes to $175.95. The forecasts range from a low of $159.00 to a high of $215.00. The average price target represents an increase of 13.15% from the last closing price of $155.50.
Analyst Price Targets (22)
Broker Rating
Johnson & Johnson currently has an average brokerage recommendation (ABR) of 2.18 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 22 brokerage firms. The current ABR compares to an ABR of 2.24 a month ago based on 21 recommendations.
Of the 22 recommendations deriving the current ABR, eight are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 36.36% and 9.09% of all recommendations. A month ago, Strong Buy made up 33.33%, while Buy represented 9.52%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 8 | 8 | 7 | 7 | 7 |
Buy | 2 | 2 | 2 | 2 | 2 |
Hold | 12 | 12 | 12 | 12 | 12 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.18 | 2.18 | 2.24 | 2.24 | 2.24 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
11/15/2024 | Not Identified | Not Identified | Not Available | Strong Buy |
11/6/2024 | Guggenheim Securities | Vamil Divan | Hold | Hold |
10/22/2024 | Daiwa America | Narumi Nakagiri | Hold | Hold |
10/15/2024 | Wells Fargo Securities | Lawrence H Biegelsen | Hold | Hold |
10/15/2024 | Not Identified | Not Identified | Hold | Hold |
9/19/2024 | Cantor Fitzgerald & Co | Louise Chen | Strong Buy | Strong Buy |
9/18/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
9/16/2024 | Not Identified | Not Identified | Hold | Hold |
9/3/2024 | UBS | Danielle Antalffy | Strong Buy | Strong Buy |
8/12/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
7/19/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
7/18/2024 | Not Identified | Not Identified | Hold | Hold |
7/18/2024 | Raymond James | Jayson T Bedford | Moderate Buy | Moderate Buy |
7/18/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
7/18/2024 | SVB Securities | David Risinger | Strong Buy | Strong Buy |
7/18/2024 | Cowen & Co. | Joshua T Jennings | Strong Buy | Strong Buy |
5/30/2024 | Goldman Sachs | Chris Shibutani | Not Available | Hold |
4/23/2024 | Atlantic Equities | Steven K Chesney | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.18 |
ABR (Last week) | 2.18 |
# of Recs in ABR | 22 |
Average Target Price | $175.95 |
LT Growth Rate | 5.70% |
Industry | Large Cap Pharmaceuticals |
Industry Rank by ABR | 82 of 252 |
Current Quarter EPS Est: | 1.99 |
JNJ FAQs
Johnson & Johnson (JNJ) currently has an average brokerage recommendation (ABR) of 2.18 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 22 brokerage firms.
The average price target for Johnson & Johnson (JNJ) is $175.95. The current on short-term price targets is based on 10 reports.
The forecasts for Johnson & Johnson (JNJ) range from a low of $159 to a high of $215. The average price target represents a increase of $13.15 from the last closing price of $155.50.
The current UPSIDE for Johnson & Johnson (JNJ) is 13.15%
Based on short-term price targets offered by 22 analysts, the average price target for Johnson & Johnson comes to $175.95. The forecasts range from a low of $159.00 to a high of $215.00. The average price target represents an increase of 13.15% from the last closing price of $155.50.